Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS

BACKGROUND: Pancreatic enzyme-replacement therapy (PERT), provided as pancreatin to patients with pancreatic exocrine insufficiency (PEI), is considered an essential substitute for the pivotal physiological function the pancreas fulfills in digestion. PEI involves a reduction in the synthesis and se...

Descripción completa

Detalles Bibliográficos
Autores principales: Maev, Igor V., Kucheryavyy, Yury A., Gubergrits, Natalya B., Bonnacker, Ingo, Shelest, Ekaterina A., Janssen-van Solingen, Gwendolyn P., Domínguez-Muñoz, J. Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691409/
https://www.ncbi.nlm.nih.gov/pubmed/33211277
http://dx.doi.org/10.1007/s40268-020-00326-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691409/
https://www.ncbi.nlm.nih.gov/pubmed/33211277
http://dx.doi.org/10.1007/s40268-020-00326-z

Ejemplares similares